---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-276426"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2024-12-12T23:59:59+00:00"
generated_at: "2026-05-29T04:01:26.030397+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# TuHURA to acquire Kineta in stock/cash merger; $35M concurrent financing required

## Summary
- Consideration per Kineta share: initial stock based on $15M pool, delayed stock based on $5M, plus cash and contingent asset payment rights.
- Closing requires TuHURA to raise at least $35M net proceeds from a concurrent private investment.
- TuHURA will loan Kineta up to $900k at 5% interest to fund R&D expenses, secured by program assets.
- Key conditions: stockholder approvals (Kineta merger vote; TuHURA authorized share increase to 200M), listing, and no law/order preventing deal.
- Termination fee of $1M payable by Kineta if it accepts a superior proposal; $1M by TuHURA if it fails to close the concurrent investment.

## SEC filing metadata
- accession: 0001193125-24-276426
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2024-12-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000119312524276426/0001193125-24-276426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000119312524276426/d881353d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-276426
- JSON: https://secwatch.observer/filing/0001193125-24-276426.json
- Plain text: https://secwatch.observer/filing/0001193125-24-276426.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.